• World
  • Columnist
  • Commodities
  • WORLD BUSINESS & ECONOMY
  • Executive Knowledge Series
  • Finance
  • Manufacturing
  • Markets
  • Risk & Governance
  • Small Business
  • Technology, Media & Innovation
  • Comments
  • Business AM WebTV
  • Login

Businessamlive
  • FRONTPAGE
  • FINANCE
    • AllAsset ManagementAuditBankingBondBudgetCapital MarketsC&I LeasingCurrencyDealDebt marketForexFund RaisingFundingGovernmentHedge FundsInsuranceInvestmentInvestorInvestor ServicesMergers & AcquistionsMoney marketTreasury BillsMortgagePensionsPersonal financePonziQuantitative EasingshareTaxationTSAWealth Management
      Companies

      Total Nigeria, Mixta, Valency, list new CPs on FMDQ platform to enhance financial markets development

      17 hrs

      Finance

      Amidst N32.22trn public debt, analysts say Nigeria’s external debt service manageable

      22 hrs

      Finance

      Stringent regulations, business environment forced Stanbic IBTC out of BDC business

      January 15, 2021

      Finance

      Cautious equities trading see gains in Flour Mills, Mobil, Wapco push market cap to ₦21.09trn

      January 15, 2021

  • MARKETS
  • ECONOMY
    • AllAfricaAgricAirportsAmericaAsiaAustraliaBreakthroughDealEuropeForeign InvestmentsforexGlobal marketGovernanceIMFMiddle EastNECANigeriaOutlookRich listSouth AfricaSport BusinessTradeU.KWest AfricaWorld Economic forum
      Commodities

      LME contemplates permanent shutdown of historic trading ring

      5 hrs

      WORLD BUSINESS & ECONOMY

      China’s economy grows 2.3%, with potentials to overtake U.S. beyond expectations

      17 hrs

      WORLD BUSINESS & ECONOMY

      Uber leads with 30% as 10 biggest startup layoffs in 2020 reach 25,000

      18 hrs

      Companies

      TIPP Oil, German lubricant maker, targets 2021 Nigeria launch with eco-friendly scheme  

      18 hrs

  • COMMODITIES
  • ENERGY
    • AllConferenceElectricityOil and GasPowerRenewable
      Companies

      TIPP Oil, German lubricant maker, targets 2021 Nigeria launch with eco-friendly scheme  

      18 hrs

      Frontpage

      Nigeria aims for cost efficiency, safety, value in oil sector with centre of excellence

      20 hrs

      Frontpage

      Sustainable energy: Minister estimates solution to cost Nigeria $4bn in annual spend

      22 hrs

      Frontpage

      NNPC receives $120.49m crude oil receipt in September  

      January 18, 2021

  • TECHNOLOGY
  • MANUFACTURING
  • ANALYSIS
    • Analyst Insight

      CBN meeting and NSE in focus

      January 18, 2021

      Analyst Insight

      Once again, fiscal stimulus takes centre stage

      January 18, 2021

      Analyst Insight

      Organisations must learn from the WhatsApp story  

      January 18, 2021

      Analyst Insight

      Data privacy maturity model in organisations

      January 11, 2021

Coronavirus Frontpage

Dexamethasone significantly cuts Covid-19 death, approved for use in U.K.

June 16, 2020839 views0 comments

Dexamethasone significantly cuts Covid-19 death, approved for use in U.K.
A pharmacist displays a box of Dexamethasone at the Erasme Hospital amid the coronavirus disease (COVID-19) outbreak, in Brussels, Belgium, June 16, 2020. REUTERS/Yves Herman

The United Kingdom on Tuesday  approved steroid dexamethasone for immediate treatment of Covid-19 patients after the drug significantly cut mortality rate among infected persons. The effectiveness of the drug among severe COVID-19 cases, in trial results, has been hailed as a “major breakthrough” in the fight against the disease.

Matt Hancock , Britain’s health secretary said the country’s patients would start to receive the drug immediately.

Hancock said the government had started stockpiling dexamethasone back in March after preliminary trials showed “early signs” of the drug’s potential.

Researchers led by a team from the University of Oxford administered the widely available drug to more than 2,000 severely ill COVID-19 patients.

Read Also:

  • Shippers Association predicts shortfall in cargo imports as covid-19…

Among those who could only breathe with the help of a ventilator, dexamethasone reduced deaths by one third, and by one-fifth in other patients receiving oxygen only, according to preliminary results.

Normally used to treat a range of allergic reactions as well as rheumatoid arthritis and asthma, dexamethasone is an anti-inflammatory.

Daily doses of the steroid could prevent one-in-eight ventilated patient deaths and save one out of every 25 patients requiring oxygen alone, the team said.

The trial, carried out by the RECOVERY research group that is searching for effective COVID-19 treatments, included a control group of 4,000 patients who did not receive the drug.

“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford.

“Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.”

Remarkable potential
The trial results are particularly promising as around 40 percent of COVID-19 patients who require a ventilator end up dying, often because of the body’s uncontrolled inflammatory response to the virus.

For those receiving the new treatment, the mortality rate dropped to less than 30 percent.

“This is a major breakthrough: dexamethasone is the first and only drug that has made a significant difference to patient mortality for COVID-19,” said Nick Cammack, COVID-19 therapeutics accelerator lead at the Wellcome Trust health charity.

“Potentially preventing one death in every eight ventilated patients would be remarkable.”

Share on Facebook Tweet Email
TagsCovid-19 Dexamethasone Dexamethasone approved in UK Dexamethasone Covid-19 treatment
PreviousHouseholds, firms to pay more for electricity from July – FG
NextSell-offs in MTN, Flourmill force Nigerian equities market down by N12bn

Leave a comment

- Cancel reply

MARKET DATA

Market Videos

Recent Posts

  • Access Bank unfolds ambitious expansion into Africa, global markets leveraging HoldCo structure
  • Nigeria bourse chief pleads caution on 2021 growth expectations
  • Selloffs in BuaCem, Access, UBA push Nigeria bourse under waters
  • Shippers Association predicts shortfall in cargo imports as covid-19 bites harder
  • LME contemplates permanent shutdown of historic trading ring

World

Africa

Buhari, Okonjo-Iweala congratulate Adesina over reelection as AfDB President

Europe

EU businesses to cut investments in 2020, says EIB report

America

U.S. increases cost of visa application for Nigerians

Africa

Thatcher-Loving Nigeria Candidate Plans to Overhaul Economy

Africa

AfDB scales up industrialization pace on the continent, delivers improved business access to finance, skills, energy

Frontpage posts

0

CBN grant banking licences to Titan Trust, Globus, Taj

Frontpage July 24, 2019

1
2

On-going restructuring of Angola state oil company to fuel national  production

Frontpage May 13, 2019

3

Larfarge, Unilever, Oando, Union Bank to raise N273bn from rights issue

Frontpage June 6, 2017

4

Petrol landing cost crashes, FG may save N450bn subsidy

Frontpage March 3, 2020

5

NSE admits Lafarge’s additional 7.43bn ordinary shares

Frontpage March 27, 2019

SUPPORT

  • Photo Gallery
  • Help Centre
  • About Us
  • Accessibility

LEGAL & PRIVACY

  • Terms & Conditions
  • Privacy
  • Cookies
  • Copyright

SERVICES

  • Conferences & Events
  • Analysts Research
  • Advertising Rate
  • Ebooks

TOOLS

  • Portfolio
  • Newsletters
  • News feed
  • Currency Converter

SUBSCRIBE

Join us to get latest updates on business related news.

[mc4wp_form id="3076"]
  • ABOUT US
  • CONTACT US
  • CAREERS
  • TERMS & CONDITIONS
  • PRIVACY POLICY
Copyright 2017. All rights reserved. BusinessAMLive. A Businessnewscorp Member Company.